Report cover image

U.S. Liquid Embolic Agent Market Size, Share, Trends, & Industry Analysis Report By Product Type (Ethylene Vinyl Alcohol Copolymer (EVOH), Cyanoacrylates, Others), By Application, By End User– Market Forecast, 2025–2034

Publisher Polaris Market Research & Consulting LLP
Published Sep 01, 2025
Length 125 Pages
SKU # PLRS20451407

Description

The U.S. liquid embolic agents market size is expected to reach USD 156.91 Million by 2034, according to a new study by Polaris Market Research. The report “U.S. Liquid Embolic Agent Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Application, By End User; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for liquid embolic agents in the U.S. is growing due to their extensive use in treating arteriovenous malformations (AVMs), intracranial aneurysms, and peripheral vascular abnormalities. These agents include ethylene vinyl alcohol (EVOH), cyanoacrylates, and other formulations, enable minimally invasive surgeries, faster patient recovery and improved procedural outcomes.

Market growth is driven by rising prevalence of cerebrovascular disorders, an aging population, increasing adoption of outpatient and hospital-based neurointerventions, and technological advancements in polymer formulations and delivery systems.

U.S. Liquid Embolic Agent Market Report Highlights

Based on product type, the ethylene vinyl alcohol copolymer (EVOH) segment dominated the market in 2024, driven by clinical reliability, strong physician preference, and established procedural outcomes.

In terms of application, the arteriovenous malformations (AVM) led the market in 2024 due to high procedural frequency and demand for precise embolization.

Based on end users, the hospitals held the largest share in 2024, fueled by advanced imaging infrastructure, trained specialists, and integrated neurointervention suites.

A few global key market players include Medtronic plc, Johnson & Johnson, Stryker Corporation, Terumo Corporation, Sirtex Medical Inc., Boston Scientific Corporation, Instylla, Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet Group S.A, Arsenal Medical Inc., and Meril Life Sciences Pvt. Ltd.

Polaris Market Research has segmented the market report on the basis of product type, application, end user:

By Product Type Outlook (Revenue, USD Million, 2020–2034)

Ethylene Vinyl Alcohol Copolymer (EVOH)

Cyanoacrylates

N-BCA (n-Butyl Cyanoacrylate)

N-HCA (n-Hexyl Cyanoacrylate)

Other Products

By Application Outlook (Revenue, USD Million, 2020–2034)

Arteriovenous Malformations (AVM)

Hypervascular Tumors

Peripheral Vasculature Hemorrhage

Other Applications

By End User Outlook (Revenue, USD Million, 2020–2034)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers (ASCs)

Other End Users

Table of Contents

125 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Liquid Embolic Agent Market Insights
4.1. U.S. Liquid Embolic Agent Market – Market Snapshot
4.2. U.S. Liquid Embolic Agent Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Incidence of Cerebrovascular Disorders in the U.S. Population
4.2.1.2. Infrastructure Investments in Hospitals and Outpatient Neurointervention Centers
4.2.2. Restraints and Challenges
4.2.2.1. High Procedural Costs and Technical Complexity
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Liquid Embolic Agent Market Trends
4.6. Value Chain Analysis
5. U.S. Liquid Embolic Agent Market, by Product Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
5.3. Ethylene Vinyl Alcohol Copolymer (EVOH)
5.3.1. U.S. Liquid Embolic Agent Market, by Ethylene Vinyl Alcohol Copolymer (EVOH), by Country, 2020-2034 (USD Million)
5.4. Cyanoacrylates
5.4.1. U.S. Liquid Embolic Agent Market, by Cyanoacrylates, by Country, 2020-2034 (USD Million)
5.5. Other Products
5.5.1. U.S. Liquid Embolic Agent Market, by Other Products, by Country, 2020-2034 (USD Million)
6. U.S. Liquid Embolic Agent Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
6.3. Arteriovenous Malformations (AVM)
6.3.1. U.S. Liquid Embolic Agent Market, by Arteriovenous Malformations (AVM), by Country, 2020-2034 (USD Million)
6.4. Hypervascular Tumors
6.4.1. U.S. Liquid Embolic Agent Market, by Hypervascular Tumors, by Country, 2020-2034 (USD Million)
6.5. Peripheral Vasculature Hemorrhage
6.5.1. U.S. Liquid Embolic Agent Market, by Peripheral Vasculature Hemorrhage, by Country, 2020-2034 (USD Million)
6.6. Other Applications
6.6.1. U.S. Liquid Embolic Agent Market, by Other Applications, by Country, 2020-2034 (USD Million)
7. U.S. Liquid Embolic Agent Market, by End User
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
7.3. Hospitals
7.3.1. U.S. Liquid Embolic Agent Market, by Hospitals, by Country, 2020-2034 (USD Million)
7.4. Specialty Clinics
7.4.1. U.S. Liquid Embolic Agent Market, by Specialty Clinics, by Country, 2020-2034 (USD Million)
7.5. Ambulatory Surgical Centers (ASCs)
7.5.1. U.S. Liquid Embolic Agent Market, by Ambulatory Surgical Centers (ASCs), by Country, 2020-2034 (USD Million)
7.6. Other End Users
7.6.1. U.S. Liquid Embolic Agent Market, by Other End Users, by Country, 2020-2034 (USD Million)
8. U.S. Liquid Embolic Agent Market, by Country
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Liquid Embolic Agent Market Assessment, By Country, 2020-2034 (USD Million)
8.2.2. U.S. Liquid Embolic Agent Market
8.2.2.1. U.S.: Liquid Embolic Agent Market, by Product Type, 2020-2034 (USD Million)
8.2.2.2. U.S.: Liquid Embolic Agent Market, by Application, 2020-2034 (USD Million)
8.2.2.3. U.S.: Liquid Embolic Agent Market, by End User, 2020-2034 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Arsenal Medical Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Boston Scientific Corporation
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Guerbet Group S.A
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Instylla, Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Johnson & Johnson
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Meril Life Sciences Pvt. Ltd.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Merit Medical Systems Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Medtronic plc
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Penumbra Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Sirtex Medical Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Stryker Corporation
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Terumo Corporation
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us